PedAM
Pediatric Disease Annotations & Medicines
| Disease | viral hepatitis |
| Phenotype | C0022658|kidney disease |
| Sentences | 1 |
| PubMedID- 25018934 | Recently published kdigo guidelines for treatment of viral hepatitis in patients with kidney disease suggest that patients with moderate proteinuria and slowly progressive kidney disease can be treated with a 12-month course of standard interferon-α or pegylated interferon-α-2a with dose adjusted as described below plus ribavirin, with or without erythropoietin support, depending on the level of hemoglobin.342 ribavirin dose needs to be titrated according to patient tolerance; caution is advised for patients with clearance <50 ml/min which may require substantially reduced dosage. |
Page: 1